{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:36:03Z","timestamp":1791776163194,"version":"4.3.4"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG093995"],"award-info":[{"award-number":["RF1AG093995"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-77335-0","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:03:36Z","timestamp":1788224616000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Fanconi anemia pathway restrains MLL-rearranged leukemogenesis through suppressing non-homologous end joining-mediated genomic instability"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2552-2553","authenticated-orcid":false,"given":"Jian","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan M.","family":"Sund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily V.","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4665-0581","authenticated-orcid":false,"given":"Anthony Z.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenxia","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawa","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3669-537X","authenticated-orcid":false,"given":"Wei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"77335_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11899-020-00582-5","volume":"15","author":"F El Chaer","year":"2020","unstructured":"El Chaer, F., Keng, M. & Ballen, K. K. MLL-rearranged acute lymphoblastic leukemia. Curr. Hematol. Malig. Rep. 15, 83\u201389 (2020).","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"77335_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fped.2017.00004","volume":"5","author":"AC Winters","year":"2017","unstructured":"Winters, A. C. & Bernt, K. M. MLL-rearranged leukemias-an update on science and clinical approaches. Front. Pediatr. 5, 4 (2017).","journal-title":"Front. Pediatr."},{"key":"77335_CR3","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/s41375-024-02235-5","volume":"38","author":"M Jassinskaja","year":"2024","unstructured":"Jassinskaja, M. et al. A complex interplay of intra- and extracellular factors regulates the outcome of fetal- and adult-derived MLL-rearranged leukemia. Leukemia 38, 1115\u20131130 (2024).","journal-title":"Leukemia"},{"key":"77335_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-27","volume":"13","author":"KK Fleischmann","year":"2014","unstructured":"Fleischmann, K. K., Pagel, P., Schmid, I. & Roscher, A. A. RNAi-mediated silencing of MLL-AF9 reveals leukemia-associated downstream targets and processes. Mol. Cancer 13, 27 (2014).","journal-title":"Mol. Cancer"},{"key":"77335_CR5","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1182\/asheducation-2011.1.354","volume":"2011","author":"KM Bernt","year":"2011","unstructured":"Bernt, K. M. & Armstrong, S. A. Targeting epigenetic programs in MLL-rearranged leukemias. Hematol. Am. Soc. Hematol. Educ. Program 2011, 354\u2013360 (2011).","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"77335_CR6","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ng.3230","volume":"47","author":"AK Andersson","year":"2015","unstructured":"Andersson, A. K. et al. The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias. Nat. Genet. 47, 330\u2013337 (2015).","journal-title":"Nat. Genet."},{"key":"77335_CR7","doi-asserted-by":"publisher","first-page":"e20190138","DOI":"10.1590\/1678-4685-gmb-2019-0138","volume":"43","author":"LMF Primo","year":"2019","unstructured":"Primo, L. M. F. & Teixeira, L. K. DNA replication stress: oncogenes in the spotlight. Genet. Mol. Biol. 43, e20190138 (2019).","journal-title":"Genet. Mol. Biol."},{"key":"77335_CR8","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.dnarep.2008.06.018","volume":"7","author":"Z Mao","year":"2008","unstructured":"Mao, Z., Bozzella, M., Seluanov, A. & Gorbunova, V. Comparison of nonhomologous end joining and homologous recombination in human cells. DNA Repair. 7, 1765\u20131771 (2008).","journal-title":"DNA Repair."},{"key":"77335_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/cr.2008.3","volume":"18","author":"E Weterings","year":"2008","unstructured":"Weterings, E. & Chen, D. J. The endless tale of non-homologous end-joining. Cell Res. 18, 114\u2013124 (2008).","journal-title":"Cell Res."},{"key":"77335_CR10","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ijc.20134","volume":"110","author":"C Welsh","year":"2004","unstructured":"Welsh, C. et al. Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines. Int. J. Cancer 110, 352\u2013361 (2004).","journal-title":"Int. J. Cancer"},{"key":"77335_CR11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/bjc.2013.303","volume":"109","author":"J Mendoza","year":"2013","unstructured":"Mendoza, J. et al. Association between ERCC1 and XPA expression and polymorphisms and the response to cisplatin in testicular germ cell tumours. Br. J. Cancer 109, 68\u201375 (2013).","journal-title":"Br. J. Cancer"},{"key":"77335_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.molcel.2010.09.019","volume":"40","author":"A Ciccia","year":"2010","unstructured":"Ciccia, A. & Elledge, S. J. The DNA damage response: making it safe to play with knives. Mol. Cell 40, 179\u2013204 (2010).","journal-title":"Mol. Cell"},{"key":"77335_CR13","doi-asserted-by":"crossref","unstructured":"Pan, M. R., Li, K., Lin, S. Y. & Hung, W. C. Connecting the dots: from DNA damage and repair to aging. Int. J. Mol. Sci. 17, 685 (2016).","DOI":"10.3390\/ijms17050685"},{"key":"77335_CR14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/carcin\/bgx002","volume":"38","author":"S Biechonski","year":"2017","unstructured":"Biechonski, S., Yassin, M. & Milyavsky, M. DNA-damage response in hematopoietic stem cells: an evolutionary trade-off between blood regeneration and leukemia suppression. Carcinogenesis 38, 367\u2013377 (2017).","journal-title":"Carcinogenesis"},{"key":"77335_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.stem.2012.05.013","volume":"11","author":"R Ceccaldi","year":"2012","unstructured":"Ceccaldi, R. et al. Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53\/p21 DNA damage response that impairs hematopoietic stem and progenitor cells. Cell Stem Cell 11, 36\u201349 (2012).","journal-title":"Cell Stem Cell"},{"key":"77335_CR16","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2174\/1389557520666200103114556","volume":"20","author":"K Ghosal","year":"2020","unstructured":"Ghosal, K. et al. Fanconi anemia DNA repair pathway as a new mechanism to exploit cancer drug resistance. Mini Rev. Med. Chem. 20, 779\u2013787 (2020).","journal-title":"Mini Rev. Med. Chem."},{"key":"77335_CR17","first-page":"64","volume":"50","author":"A Murthy","year":"2024","unstructured":"Murthy, A. & Tirado, C. A. Fanconi anemia, AML, and MDS. J. Assoc. Genet Technol. 50, 64\u201368 (2024).","journal-title":"J. Assoc. Genet Technol."},{"key":"77335_CR18","doi-asserted-by":"publisher","first-page":"909","DOI":"10.15252\/embj.201693860","volume":"35","author":"J Michl","year":"2016","unstructured":"Michl, J., Zimmer, J. & Tarsounas, M. Interplay between Fanconi anemia and homologous recombination pathways in genome integrity. EMBO J. 35, 909\u2013923 (2016).","journal-title":"EMBO J."},{"key":"77335_CR19","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41586-022-05253-4","volume":"612","author":"ALH Webster","year":"2022","unstructured":"Webster, A. L. H. et al. Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer. Nature 612, 495\u2013502 (2022).","journal-title":"Nature"},{"key":"77335_CR20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/00062752-200301000-00011","volume":"10","author":"GC Bagby Jr.","year":"2003","unstructured":"Bagby, G. C. Jr. Genetic basis of Fanconi anemia. Curr. Opin. Hematol. 10, 68\u201376 (2003).","journal-title":"Curr. Opin. Hematol."},{"key":"77335_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.hoc.2009.01.008","volume":"23","author":"AM Green","year":"2009","unstructured":"Green, A. M. & Kupfer, G. M. Fanconi anemia. Hematol. Oncol. Clin. North Am. 23, 193\u2013214 (2009).","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"77335_CR22","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nrm.2017.53","volume":"18","author":"A Ray Chaudhuri","year":"2017","unstructured":"Ray Chaudhuri, A. & Nussenzweig, A. The multifaceted roles of PARP1 in DNA repair and chromatin remodelling. Nat. Rev. Mol. Cell Biol. 18, 610\u2013621 (2017).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"77335_CR23","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1083\/jcb.201012132","volume":"194","author":"CA Couto","year":"2011","unstructured":"Couto, C. A. et al. PARP regulates nonhomologous end joining through retention of Ku at double-strand breaks. J. Cell Biol. 194, 367\u2013375 (2011).","journal-title":"J. Cell Biol."},{"key":"77335_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/srep22167","volume":"6","author":"W Du","year":"2016","unstructured":"Du, W., Amarachintha, S., Wilson, A. F. & Pang, Q. Hyper-active non-homologous end joining selects for synthetic lethality resistant and pathological Fanconi anemia hematopoietic stem and progenitor cells. Sci. Rep. 6, 22167 (2016).","journal-title":"Sci. Rep."},{"key":"77335_CR25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41392-020-00358-6","volume":"5","author":"S Li","year":"2020","unstructured":"Li, S. et al. Development of synthetic lethality in cancer: molecular and cellular classification. Signal Transduct. Target Ther. 5, 241 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"77335_CR26","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1158\/1078-0432.CCR-15-0088","volume":"21","author":"KS Tewari","year":"2015","unstructured":"Tewari, K. S., Eskander, R. N. & Monk, B. J. Development of olaparib for BRCA-deficient recurrent epithelial ovarian cancer. Clin. Cancer Res. 21, 3829\u20133835 (2015).","journal-title":"Clin. Cancer Res."},{"key":"77335_CR27","doi-asserted-by":"crossref","unstructured":"Li, X. & Zou, L. BRCAness, DNA gaps, and gain and loss of PARP inhibitor-induced synthetic lethality. J. Clin. Invest. 134, e181062 (2024).","DOI":"10.1172\/JCI181062"},{"key":"77335_CR28","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1101\/gad.1370505","volume":"19","author":"RD Kennedy","year":"2005","unstructured":"Kennedy, R. D. & D\u2019Andrea, A. D. The Fanconi anemia\/BRCA pathway: new faces in the crowd. Genes Dev. 19, 2925\u20132940 (2005).","journal-title":"Genes Dev."},{"key":"77335_CR29","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1182\/blood-2010-09-308726","volume":"117","author":"S Quentin","year":"2011","unstructured":"Quentin, S. et al. Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1\/AML1 lesions. Blood 117, e161\u2013e170 (2011).","journal-title":"Blood"},{"key":"77335_CR30","doi-asserted-by":"crossref","unstructured":"Merfort, L. W., Lisboa, M. O., Cavalli, L. R. & Bonfim, C. M. S. Cytogenetics in Fanconi anemia: the importance of follow-up and the search for new biomarkers of genomic instability. Int. J. Mol. Sci. 23, 14119 (2022).","DOI":"10.3390\/ijms232214119"},{"key":"77335_CR31","doi-asserted-by":"publisher","first-page":"37436","DOI":"10.1074\/jbc.M110.113209","volume":"285","author":"W Du","year":"2010","unstructured":"Du, W., Li, J., Sipple, J., Chen, J. & Pang, Q. Cytoplasmic FANCA-FANCC complex interacts and stabilizes the cytoplasm-dislocalized leukemic nucleophosmin protein (NPMc). J. Biol. Chem. 285, 37436\u201337444 (2010).","journal-title":"J. Biol. Chem."},{"key":"77335_CR32","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ccr.2008.04.020","volume":"13","author":"J Wei","year":"2008","unstructured":"Wei, J. et al. Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia. Cancer Cell 13, 483\u2013495 (2008).","journal-title":"Cancer Cell"},{"key":"77335_CR33","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nature07849","volume":"458","author":"PJ Cook","year":"2009","unstructured":"Cook, P. J. et al. Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions. Nature 458, 591\u2013596 (2009).","journal-title":"Nature"},{"key":"77335_CR34","doi-asserted-by":"publisher","first-page":"16066","DOI":"10.1074\/jbc.C900032200","volume":"284","author":"N Krishnan","year":"2009","unstructured":"Krishnan, N. et al. Dephosphorylation of the C-terminal tyrosyl residue of the DNA damage-related histone H2A.X is mediated by the protein phosphatase eyes absent. J. Biol. Chem. 284, 16066\u201316070 (2009).","journal-title":"J. Biol. Chem."},{"key":"77335_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature07668","volume":"457","author":"A Xiao","year":"2009","unstructured":"Xiao, A. et al. WSTF regulates the H2A.X DNA damage response via a novel tyrosine kinase activity. Nature 457, 57\u201362 (2009).","journal-title":"Nature"},{"key":"77335_CR36","doi-asserted-by":"crossref","unstructured":"Lin, Q. et al. Persistent DNA damage-induced NLRP12 improves hematopoietic stem cell function. JCI Insight 5, e133365 (2020).","DOI":"10.1172\/jci.insight.133365"},{"key":"77335_CR37","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1038\/sj.emboj.7601115","volume":"25","author":"L Cao","year":"2006","unstructured":"Cao, L. et al. ATM-Chk2-p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiency. EMBO J. 25, 2167\u20132177 (2006).","journal-title":"EMBO J."},{"key":"77335_CR38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/1078-0432.CCR-10-1215","volume":"17","author":"A Stolz","year":"2011","unstructured":"Stolz, A., Ertych, N. & Bastians, H. Tumor suppressor CHK2: regulator of DNA damage response and mediator of chromosomal stability. Clin. Cancer Res. 17, 401\u2013405 (2011).","journal-title":"Clin. Cancer Res."},{"key":"77335_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nprot.2006.5","volume":"1","author":"PL Olive","year":"2006","unstructured":"Olive, P. L. & Ban\u00e1th, J. P. The comet assay: a method to measure DNA damage in individual cells. Nat. Protoc. 1, 23\u201329 (2006).","journal-title":"Nat. Protoc."},{"key":"77335_CR40","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0092-8674(03)00567-1","volume":"114","author":"A Celeste","year":"2003","unstructured":"Celeste, A. et al. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell 114, 371\u2013383 (2003).","journal-title":"Cell"},{"key":"77335_CR41","first-page":"6008","volume":"63","author":"SJ Veuger","year":"2003","unstructured":"Veuger, S. J., Curtin, N. J., Richardson, C. J., Smith, G. C. & Durkacz, B. W. Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1. Cancer Res 63, 6008\u20136015 (2003).","journal-title":"Cancer Res"},{"key":"77335_CR42","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1126\/science.1202723","volume":"332","author":"Z Mao","year":"2011","unstructured":"Mao, Z. et al. SIRT6 promotes DNA repair under stress by activating PARP1. Science 332, 1443\u20131446 (2011).","journal-title":"Science"},{"key":"77335_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.807200","volume":"11","author":"H Si","year":"2021","unstructured":"Si, H. et al. Identification of U937(JAK3-M511I) acute myeloid leukemia cells as a sensitive model to JAK3 inhibitor. Front. Oncol. 11, 807200 (2021).","journal-title":"Front. Oncol."},{"key":"77335_CR44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1471-2172-10-18","volume":"10","author":"YS Baek","year":"2009","unstructured":"Baek, Y. S. et al. Identification of novel transcriptional regulators involved in macrophage differentiation and activation in U937 cells. BMC Immunol. 10, 18 (2009).","journal-title":"BMC Immunol."},{"key":"77335_CR45","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/cyto.b.22051","volume":"102","author":"S Konoplev","year":"2022","unstructured":"Konoplev, S. et al. Comprehensive immunophenotypic study of acute myeloid leukemia with KMT2A (MLL) rearrangement in adults: a single-institution experience. Cytom. B Clin. Cytom. 102, 123\u2013133 (2022).","journal-title":"Cytom. B Clin. Cytom."},{"key":"77335_CR46","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40164-022-00343-5","volume":"11","author":"TM Tran","year":"2022","unstructured":"Tran, T. M. & Rao, D. S. RNA binding proteins in MLL-rearranged leukemia. Exp. Hematol. Oncol. 11, 80 (2022).","journal-title":"Exp. Hematol. Oncol."},{"key":"77335_CR47","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1038\/leu.2010.158","volume":"24","author":"M Wunderlich","year":"2010","unstructured":"Wunderlich, M. et al. AML xenograft efficiency is significantly improved in NOD\/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3. Leukemia 24, 1785\u20131788 (2010).","journal-title":"Leukemia"},{"key":"77335_CR48","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1158\/0008-5472.CAN-23-3005","volume":"84","author":"W Zhang","year":"2024","unstructured":"Zhang, W. et al. Integration of pan-cancer cell line and single-cell transcriptomic profiles enables inference of therapeutic vulnerabilities in heterogeneous tumors. Cancer Res. 84, 2021\u20132033 (2024).","journal-title":"Cancer Res."},{"key":"77335_CR49","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/S1470-2045(24)00386-3","volume":"25","author":"ES Wang","year":"2024","unstructured":"Wang, E. S. et al. Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial. Lancet Oncol. 25, 1310\u20131324 (2024).","journal-title":"Lancet Oncol."},{"key":"77335_CR50","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/NEJMoa1614359","volume":"377","author":"RM Stone","year":"2017","unstructured":"Stone, R. M. et al. Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation. N. Engl. J. Med. 377, 454\u2013464 (2017).","journal-title":"N. Engl. J. Med."},{"key":"77335_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27300-w","volume":"12","author":"L Wu","year":"2021","unstructured":"Wu, L. et al. Quinacrine-CASIN combination overcomes chemoresistance in human acute lymphoid leukemia. Nat. Commun. 12, 6936 (2021).","journal-title":"Nat. Commun."},{"key":"77335_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01834-4","volume":"8","author":"A Di Tullio","year":"2017","unstructured":"Di Tullio, A. et al. The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia. Nat. Commun. 8, 1679 (2017).","journal-title":"Nat. Commun."},{"key":"77335_CR53","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ccr.2012.01.021","volume":"21","author":"S Takacova","year":"2012","unstructured":"Takacova, S. et al. DNA damage response and inflammatory signaling limit the MLL-ENL-induced leukemogenesis in vivo. Cancer Cell 21, 517\u2013531 (2012).","journal-title":"Cancer Cell"},{"key":"77335_CR54","doi-asserted-by":"publisher","first-page":"7037","DOI":"10.1074\/jbc.M112.434498","volume":"288","author":"AJ Davis","year":"2013","unstructured":"Davis, A. J., Lee, K. J. & Chen, D. J. The N-terminal region of the DNA-dependent protein kinase catalytic subunit is required for its DNA double-stranded break-mediated activation. J. Biol. Chem. 288, 7037\u20137046 (2013).","journal-title":"J. Biol. Chem."},{"key":"77335_CR55","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature09350","volume":"467","author":"H Liu","year":"2010","unstructured":"Liu, H. et al. Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint. Nature 467, 343\u2013346 (2010).","journal-title":"Nature"},{"key":"77335_CR56","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev-pathol-011811-132434","volume":"7","author":"AG Muntean","year":"2012","unstructured":"Muntean, A. G. & Hess, J. L. The pathogenesis of mixed-lineage leukemia. Annu. Rev. Pathol. 7, 283\u2013301 (2012).","journal-title":"Annu. Rev. Pathol."},{"key":"77335_CR57","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13045-021-01057-7","volume":"14","author":"X Li","year":"2021","unstructured":"Li, X. & Song, Y. Structure, function and inhibition of critical protein-protein interactions involving mixed lineage leukemia 1 and its fusion oncoproteins. J. Hematol. Oncol. 14, 56 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"77335_CR58","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nrc2253","volume":"7","author":"AV Krivtsov","year":"2007","unstructured":"Krivtsov, A. V. & Armstrong, S. A. MLL translocations, histone modifications and leukaemia stem-cell development. Nat. Rev. Cancer 7, 823\u2013833 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"77335_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70326","volume":"13","author":"L Yin","year":"2024","unstructured":"Yin, L., Wan, L., Zhang, Y., Hua, S. & Shao, X. Recent developments and evolving therapeutic strategies in KMT2A-rearranged acute leukemia. Cancer Med 13, e70326 (2024).","journal-title":"Cancer Med"},{"key":"77335_CR60","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.1182\/bloodadvances.2021004580","volume":"5","author":"G Richard-Carpentier","year":"2021","unstructured":"Richard-Carpentier, G. et al. Outcomes of acute lymphoblastic leukemia with KMT2A (MLL) rearrangement: the MD Anderson experience. Blood Adv. 5, 5415\u20135419 (2021).","journal-title":"Blood Adv."},{"key":"77335_CR61","doi-asserted-by":"publisher","first-page":"10287","DOI":"10.1093\/nar\/gks798","volume":"40","author":"J Krietsch","year":"2012","unstructured":"Krietsch, J. et al. PARP activation regulates the RNA-binding protein NONO in the DNA damage response to DNA double-strand breaks. Nucleic Acids Res. 40, 10287\u201310301 (2012).","journal-title":"Nucleic Acids Res."},{"key":"77335_CR62","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.molcel.2018.06.004","volume":"71","author":"H Hanzlikova","year":"2018","unstructured":"Hanzlikova, H. et al. The importance of poly(ADP-ribose) polymerase as a sensor of unligated Okazaki fragments during DNA replication. Mol. Cell 71, 319\u2013331.e313 (2018).","journal-title":"Mol. Cell"},{"key":"77335_CR63","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.molcel.2010.06.026","volume":"39","author":"A Adamo","year":"2010","unstructured":"Adamo, A. et al. Preventing nonhomologous end joining suppresses DNA repair defects of Fanconi anemia. Mol. Cell 39, 25\u201335 (2010).","journal-title":"Mol. Cell"},{"key":"77335_CR64","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1093\/hmg\/ddg219","volume":"12","author":"JC Wong","year":"2003","unstructured":"Wong, J. C. et al. Targeted disruption of exons 1 to 6 of the Fanconi Anemia group A gene leads to growth retardation, strain-specific microphthalmia, meiotic defects and primordial germ cell hypoplasia. Hum. Mol. Genet. 12, 2063\u20132076 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"77335_CR65","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ng0496-448","volume":"12","author":"M Chen","year":"1996","unstructured":"Chen, M. et al. Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nat. Genet. 12, 448\u2013451 (1996).","journal-title":"Nat. Genet."},{"key":"77335_CR66","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1101\/gad.1103403","volume":"17","author":"S Houghtaling","year":"2003","unstructured":"Houghtaling, S. et al. Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes Dev. 17, 2021\u20132035 (2003).","journal-title":"Genes Dev."},{"key":"77335_CR67","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.1182\/blood-2003-07-2527","volume":"103","author":"E Willmore","year":"2004","unstructured":"Willmore, E. et al. A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia. Blood 103, 4659\u20134665 (2004).","journal-title":"Blood"},{"key":"77335_CR68","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1038\/s41375-022-01707-w","volume":"36","author":"W Fiskus","year":"2022","unstructured":"Fiskus, W. et al. Activity of menin inhibitor ziftomenib (KO-539) as monotherapy or in combinations against AML cells with MLL1 rearrangement or mutant NPM1. Leukemia 36, 2729\u20132733 (2022).","journal-title":"Leukemia"},{"key":"77335_CR69","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1182\/blood-2010-09-309179","volume":"117","author":"W Du","year":"2011","unstructured":"Du, W., Li, X. E., Sipple, J. & Pang, Q. Overexpression of IL-3R\u03b1 on CD34+CD38- stem cells defines leukemia-initiating cells in Fanconi anemia AML. Blood 117, 4243\u20134252 (2011).","journal-title":"Blood"},{"key":"77335_CR70","doi-asserted-by":"crossref","unstructured":"Babin, L., et al. From circRNAs to fusion circRNAs in hematological malignancies. JCI Insight 6, e151513 (2021).","DOI":"10.1172\/jci.insight.151513"},{"key":"77335_CR71","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1182\/blood.V90.6.2293","volume":"90","author":"GP Reddy","year":"1997","unstructured":"Reddy, G. P. et al. Cell cycle analysis and synchronization of pluripotent hematopoietic progenitor stem cells. Blood 90, 2293\u20132299 (1997).","journal-title":"Blood"},{"key":"77335_CR72","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/leu.2016.242","volume":"31","author":"W Du","year":"2017","unstructured":"Du, W., Amarachintha, S., Wilson, A. & Pang, Q. The immune receptor Trem1 cooperates with diminished DNA damage response to induce preleukemic stem cell expansion. Leukemia 31, 423\u2013433 (2017).","journal-title":"Leukemia"},{"key":"77335_CR73","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/nmeth947","volume":"3","author":"O S\u00f6derberg","year":"2006","unstructured":"S\u00f6derberg, O. et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods 3, 995\u20131000 (2006).","journal-title":"Nat. Methods"},{"key":"77335_CR74","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jim.2009.06.008","volume":"347","author":"Y Hu","year":"2009","unstructured":"Hu, Y. & Smyth, G. K. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J. Immunol. Methods 347, 70\u201378 (2009).","journal-title":"J. Immunol. Methods"},{"key":"77335_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/srep18127","volume":"5","author":"W Du","year":"2015","unstructured":"Du, W. et al. Fancb deficiency impairs hematopoietic stem cell function. Sci. Rep. 5, 18127 (2015).","journal-title":"Sci. Rep."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77335-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77335-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77335-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:03:30Z","timestamp":1790813010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77335-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77335"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77335-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10384"}}